本页面由Tiger Trade Technology Pte. Ltd.提供服务

Recursion Pharmaceuticals, Inc.

3.05
+0.04001.33%
盘后3.050.00000.00%16:13 EDT
成交量:2,429.16万
成交额:7,242.86万
市值:16.09亿
市盈率:-2.61
高:3.05
开:2.98
低:2.86
收:3.01
52周最高:7.18
52周最低:2.77
股本:5.27亿
流通股本:5.12亿
量比:1.39
换手率:4.75%
股息:- -
股息率:- -
每股收益(TTM):-1.1684
每股收益(LYR):-1.4410
净资产收益率:-57.16%
总资产收益率:-27.66%
市净率:1.57
市盈率(LYR):-2.12

数据加载中...

2026/07/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/18

重要事件披露

Form 8-K - Current report
2026/06/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities